Thermo Fisher (TMO) announced a 10-year virtual power purchasing agreement with international renewable energy developer X-ELIO designed to increase access to renewable electricity across the pharmaceutical and healthcare supply chains. The Lorca solar project is expected to be operational in early 2026 and includes a cohort of three partners from the pharmaceutical and healthcare sectors.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on TMO:
- Thermo Fisher price target raised to $650 from $605 at Scotiabank
- Thermo Fisher’s Strong 2024 Earnings Call Insights
- Thermo Fisher price target raised, named a ‘Top Pick’ at Morgan Stanley
- Thermo Fisher price target raised to $690 from $630 at Bernstein
- Thermo Fisher price target raised to $693 from $689 at RBC Capital